维普期刊资源整合服务平台（V6.5）

56篇 您的检索式：作者名="Mehmi"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report显示文摘Dear Editor,I am Dr.Daniel Russell Richardson from the West Virginia University Eye Institute in Morgantown,West Virginia,United States.I write to present a case of uveitis associated with nivolumab,which is a promising new immune checkpoint inhibitor(ICI)for metastatic melanoma and non-small cell lung carcinoma with expanding indications.As the use of nivolumab continues to increase,ophthalmologists must be aware of uveitis as an adverse event.Modulating	Daniel Russell Richardson Brian Ellis Inderjit Mehmi Monique Leys	2017	International Journal of Ophthalmology(English edition)2017，10，7：	3
2	A novel CYR61-triggered CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ ERK2 MAPK signaling pathway 显示文摘	Menendez JA Vellon L Mehmi I	2005	Oncogene2005，24，5：	1
3	Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage显示文摘	Menendez JA Mehmi I Lupu R	2005	Int J Oncol2005，26，3：	1
4	Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer显示文摘	Tsai M S Shamon-Taylor L A Mehmi I	2003	Oncogene2003，22，5：	1
5	Inhibition of fatty acid synthase (FAS) suppresses Her-2/neu (erbB-2) oncogene overexpression in cancer cells显示文摘	Menendez J A Vellon L Mehmi I	2004	Proc Natl Acad Sci U S A2004，101，10：	1
6	Inhibition of fatty acid synthase (FAS)suppresses HER2/nuc (erbB2)oncogene overexpression in cancer cells显示文摘	Velon L Mehmi I	2004	Proc Natl Acad Sci U S A2004，101，10：	1
7	A novel CYR61-triggered CYR61-alphavbeta3 integrin loop' regulates breast cancer cell sur-vival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway显示文摘	Menendez JA Vellon L Mehmi I	2005	Oncogene2005，24，5：	1
8	The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives 显示文摘	Menendez JA Mehmi I Griggs DW	2003	Endocr Relat Cancer2003，10，2：	1
9	Ihibition of fatty acid synthase (FAS) suppressesHER2/neu ( crbB-2 ) oncogene over- expression in cancer ceils 显示文摘	Menendez JA Vellon L Mehmi I	2004	Proc Natl Acad Sci USA2004，101，10：	1
10	A novel CYR61- triggered ‘CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway 显示文摘	Menendez JA Vellon L Mehmi I	2005	Oncogene2005，24，：	1
11	Inhibition of fatty acid syn- thase (FAS) suppresses HER2/neu ( erbB - 2 ) oncogene overexpres- sion in cancer cells 显示文摘	Menendez JA Vellon L Mehmi I	2004	Proc Natl Acad Sci U S A2004，101，10：	1
12	The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives显示文摘	JA Mene'ndez I Mehmi DW Griggs	2003	Endo Rel Cancer2003，10，2：	1
13	A novel CYR61- triggered ‘CYR61-avb3 integrin loop regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway 显示文摘	Javier A Menendez Luciano Vellon Inderjit Mehmi	2005	Oncogene2005，24，5：	1
14	Over expression and hyperactivity of breast cancer-associated fatty acid synthase(oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids:a novel mechanism by which dietary fat can alter mammary tumorigenesis显示文摘	Menendez J A Ropero S Mehmi I	2004	Int J Oncol2004，24，6：	1
15	A novel CYR61-triggered CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway显示文摘	Vellon L Mehmi I	2005	Oncogene2005，24，：	1
16	Black cohosh, amenopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth显示文摘	Lupu R Mehmi I Atlas E	2003	Int J Oncol2003，23，5：	1
17	A novel CYR61 - triggered CYR61 - alphavbeta3 integrin loop'regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway显示文摘	Menendez JA Vellon L Mehmi I	2005	Oncogene2005，24，5：	1
18	Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB22) oncogene overexpression in cancer cells显示文摘	Menendez J A Vellon L Mehmi I	2004	Proc Natl Acad Sci USA2004，101，10：	1
19	Pharmacological inhibition of fatty acid synthase (FAS):a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformtion显示文摘	Menendez JA Mehmi I Verma VA	2004	Mol Carcinog2004，41，3：	1
20	Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids:a novel mechanism by which dietary fat can alter mammary tumorigenesis显示文摘	Menendez J A Ropero S Mehmi I		Int J Oncol0，24，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示